Photobiomodulation therapy as an adjunct to occlusal splint therapy in the management of temporomandibular disorders: a narrative review
Аннотация
Purpose To synthesise the randomised evidence comparing and combining photobiomodulation therapy (PBMT) and occlusal splint therapy in temporomandibular disorders (TMD), to determine whether the two modalities are interchangeable, additive or complementary, and to identify the methodological barriers preventing translation into a chairside protocol. Methods MEDLINE via PubMed was searched, combining controlled vocabulary and free-text terms for photobiomodulation, low-level light therapy, occlusal splints and temporomandibular joint disorders. Priority was given to randomised controlled trials using occlusal splint therapy as comparator or co-intervention, and to systematic reviews and network meta-analyses including both modalities. Mechanistic literature was selected purposively. Results Head-to-head trials support approximate short-term equivalence for pain and mandibular movement, although one double-blind trial found a Michigan splint superior to an abbreviated laser protocol. Combination trials generally favour combined therapy across muscular TMD, mixed myofascial and arthralgic populations, laser and light-emitting diode sources, and chronic closed lock. Network meta-analyses rank both modalities among the effective initial conservative options but at very low certainty; PBMT ranks best for maximum mouth opening in disc displacement with reduction. The dominant limitation is dosimetric heterogeneity, compounded by the biphasic dose response and the absence of irradiance reciprocity. Conclusion PBMT is best positioned as an adjunct rather than a substitute: the evidence is most consistent with it providing early analgesia while the splint sustains the longer-term gain. Wavelength-specific dosing, complete parameter reporting, DC/TMD phenotyping and multi-centre trials are required before an evidence-based chairside protocol can be defined.